Skip to main content
. 2017 Aug 4;8(40):69139–69161. doi: 10.18632/oncotarget.19932

Table 2. Inhibitors of STAT3 in development and angiogenesis.

Inhibitors Cell/Tissues Mechanisms References
Natural
Scoparone VSMC Blocks the transportation of STAT3 from the cytosol to the nucleus [169]
Indoxyl sulfate Mouse EPCs/ human EPCs Unclear [182]
adiponectin Human VSM and VECs Induces SOCS to inhibit STAT3 [184]
melatonin HepG2/HeLa/ HUVECs Unclear [186]
Tanshinone I Vascular endothelial cells/ tumor Inhibits STAT3 705 Tyr-phosphorylation [85]
Indirubin Human endothelial cells/ tumor Inhibits VEGFR/JAK2/ STAT3 phosphorylation [178]
Wogonin Tumor/ HUVECs Inhibits STAT3 705 Tyr-phosphorylation and promotes dephosphorylation [172]
Astaxanthin Tumor Inhibit STAT3 phosphorylation [170]
GYY4137 Human hepatocellular carcinoma (HCC) Inhibits JAK2/STAT3 [195]
Icaritin Renal cell carcinoma Inhibits IL-6-induced STAT3 705 Tyr-phosphorylation [191]
Butein Human Multiple Myeloma/ tumor Induces SHP-1 to dephosphorylate JAK2 and STAT3 [199]
resveratrol Tumor Induces GRIM19 to inhibit STAT3 [203]
Acacetin HUVECs/ tumor Inhibits STAT3 705 Tyr-phosphorylation [187]
α -Solanine Tumor Unclear [205]
JSI-124 (Cucurbitacin I) Tumor Unclear [183]
Synthetic
TEL03 Tumor Inhibits STAT3 phosphorylation by interacting with SH2 domain [190]
LCB03-0110 Human endothelial cells/ tumor Targets VEGFR-2 kinase activity by binding to the ATP-binding site [177]
P3971 Tumor Unclear [185]